findmyKOL
Clinical trialNCT01026233CompletedPhase 1Interventional

Cardiac Safety Study of Brentuximab Vedotin (SGN-35)

SponsorSeagen Inc.Enrollment52Disease, HodgkinLymphoma, Large-Cell, AnaplasticLymphoma, Non-Hodgkin
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Germany
  • University Hospital of Cologne

    Cologne, Germany

United States
  • University of Alabama at Birmingham

    Birmingham, Alabama, United States

  • City of Hope National Medical Center

    Duarte, California, United States

  • Stanford Cancer Center

    Stanford, California, United States

  • University of Miami Hospital and Clinics, Miller School of Medicine

    Miami, Florida, United States

  • Cardinal Bernardin Cancer Center / Loyola University Medical Center

    Maywood, Illinois, United States

  • New York University Cancer Institute

    New York, New York, United States

  • Fox Chase Cancer Center

    Philadelphia, Pennsylvania, United States

  • Baylor University Medical Center

    Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2010
Primary completion
31 Aug 2010
Completion
31 Aug 2011
Last update posted
12 Dec 2014
Registered enrollment
52
Registry id
NCT01026233

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.